Dietrich G V
Abteilung Anaesthesiologie und Operative Intensivmedizin, Justus-Liebig-Universität Giessen.
Zentralbl Chir. 1996;121(10):841-6.
Cost-efficiency analysis for autologous transfusions begins with the calculation of the pure production costs. They amount to $35-$75 for one unit of red blood cell concentrate (RBC). One homologous RBC is billed with $80 in Germany. Following factors further increase costs of an autologous blood predeposit: Autologous blood frequently is transfused more generously. The expiration-rate of autologous blood is higher. The haemoglobin content of the second and following RBC is lower. The patient himself has lower haemoglobin on the day of surgery after an autologous blood donation. In scientific examinations it is possible to refer additional costs of autologous blood to a gained "quality adjusted life year". They amount to $40,000 to $1,800,000.
自体输血的成本效益分析始于纯生产成本的计算。每单位浓缩红细胞(RBC)的成本为35 - 75美元。在德国,一单位同种异体RBC的收费为80美元。以下因素会进一步增加自体血预存的成本:自体血的输注量通常更大;自体血的过期率更高;第二次及后续RBC的血红蛋白含量更低;自体献血后,患者在手术当天的血红蛋白水平更低。在科学研究中,可以将自体血的额外成本与获得的“质量调整生命年”相关联。这些成本在40,000美元至1,800,000美元之间。